Cancer Cell Cycles
暂无分享,去创建一个
[1] B. Stewart. On Systematic Sun-Spot Periodicity , 1880, Nature.
[2] John Griffith. British Place-names in their Historical Setting , 1910, Nature.
[3] G. W. Bohn,et al. IMMUNITY TO FUSARIUM WILT IN THE TOMATO. , 1939, Science.
[4] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Kessin. Mutations causing rapid development of Dictyostelium discoideum , 1977, Cell.
[6] D. J. Mcfarland. Decision making in animals , 1977, Nature.
[7] E. Ashby. Social impact of technology , 1978, Nature.
[8] V. Devita,et al. Cancer : Principles and Practice of Oncology , 1982 .
[9] G. Steele,et al. Cancer: Principles and Practice of Oncology , 1983 .
[10] Comprehensive textbook of oncology , 1986 .
[11] A. Pardee. G1 events and regulation of cell proliferation. , 1989, Science.
[12] C. Bréchot,et al. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma , 1990, Nature.
[13] W. Bray. Colour consciousness in archaeology , 1990, Nature.
[14] A. Kimchi,et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.
[15] A. Arnold,et al. A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.
[16] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[17] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[18] L. Donehower,et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.
[19] R. Weinberg,et al. Effects of an Rb mutation in the mouse , 1992, Nature.
[20] M. Kastan,et al. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[21] A. Murray,et al. Creative blocks: cell-cycle checkpoints and feedback controls , 1992, Nature.
[22] J. Nevins,et al. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.
[23] P. Meltzer,et al. Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.
[24] G. Wahl,et al. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.
[25] R. Weinberg,et al. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins , 1992, Cell.
[26] A. Bradley,et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis , 1992, Nature.
[27] A. Berns,et al. Requirement for a functional Rb-1 gene in murine development , 1992, Nature.
[28] S. Weintraub,et al. Retinoblastoma protein switches the E2F site from positive to negative element , 1992, Nature.
[29] R. Pepperkok,et al. Cyclin A is required at two points in the human cell cycle. , 1992, The EMBO journal.
[30] D. Lane,et al. p53, guardian of the genome , 1992, Nature.
[31] Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. , 1992, Molecular and cellular biology.
[32] S. Reed,et al. The role of p34 kinases in the G1 to S-phase transition. , 1992, Annual review of cell biology.
[33] P. Nurse,et al. Animal cell cycles and their control. , 1992, Annual review of biochemistry.
[34] P. Shaw,et al. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] Thea D. Tlsty,et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.
[36] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[37] C. Purdie,et al. Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.
[38] Pengcheng Zhou,et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. , 1993, Oncogene.
[39] L. Donehower,et al. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. , 1993, Oncogene.
[40] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[41] David M. Livingston,et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.
[42] S. Shurtleff,et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. , 1993, Genes & development.
[43] James M. Roberts,et al. A link between cyclin A expression and adhesion-dependent cell cycle progression. , 1993, Science.
[44] M. Pagano,et al. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. , 1993, Genes & development.
[45] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[46] E. Lam,et al. An E2F‐binding site mediates cell‐cycle regulated repression of mouse B‐myb transcription. , 1993, The EMBO journal.
[47] M. Ewen,et al. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. , 1993, Genes & development.
[48] E. White,et al. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.
[49] C. Turck,et al. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit , 1993, Nature.
[50] M. Solomon,et al. Activation of the various cyclin/cdc2 protein kinases. , 1993, Current opinion in cell biology.
[51] K. Helin,et al. The retinoblastoma protein as a transcriptional repressor. , 1993, Trends in cell biology.
[52] S. Lowe,et al. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. , 1993, Genes & development.
[53] D. Housman,et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.
[54] James M. Roberts,et al. Cyclin-dependent regulation of G1 in mammalian fibroblasts. , 1993, Science.
[55] K Nasmyth,et al. Control of the yeast cell cycle by the Cdc28 protein kinase. , 1993, Current opinion in cell biology.
[56] Bert Vogelstein,et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.
[57] Scott W. Lowe,et al. p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.
[58] A. Levine,et al. p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[59] J. Bartek,et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1 , 1994, The Journal of cell biology.
[60] T. Graeber,et al. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.
[61] L. M. Facchini,et al. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. , 1994, Oncogene.
[62] W. Kaelin,et al. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[63] H. Hermeking,et al. Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.
[64] A. Levine,et al. Functions of the p53 protein in growth regulation and tumor suppression. , 1994, Cold Spring Harbor symposia on quantitative biology.
[65] J. Massagué,et al. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27 Kip1 ) of cyclin-dependent kinase 4 activation , 1994, Cell.
[66] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.
[67] James M. Roberts,et al. Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.
[68] E. Lam,et al. DP and E2F proteins: coordinating transcription with cell cycle progression. , 1994, Current opinion in cell biology.
[69] James M. Roberts,et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.
[70] E. Lees,et al. Cyclin E, a potential prognostic marker for breast cancer. , 1994, Cancer research.
[71] Kathleen R. Cho,et al. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[72] J. Nevins,et al. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. , 1994, Genes & development.
[73] R. Weinberg,et al. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. , 1994, Genes & development.
[74] S. Elledge,et al. Cdk inhibitors: on the threshold of checkpoints and development. , 1994, Current opinion in cell biology.
[75] T. Hunter,et al. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.
[76] D. Carson,et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.
[77] John Calvin Reed,et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. , 1994, Oncogene.
[78] M. Pagano,et al. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression. , 1994, Oncogene.
[79] W. Lee,et al. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis , 1994, Molecular and cellular biology.
[80] B. Dynlacht,et al. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. , 1994, Genes & development.
[81] D. Albert,et al. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. , 1994, Genes & development.
[82] A. Abbott. Rome "could host European mouse laboratory" , 1994, Nature.
[83] Van Dyke Ta,et al. Analysis of viral-host protein interactions and tumorigenesis in transgenic mice. , 1994 .
[84] S. Lowe,et al. p53-Dependent apoptosis suppresses tumor growth and progression in vivo , 1994, Cell.
[85] C. O'keefe,et al. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. , 1994, Genes & development.
[86] J. R. Smith,et al. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.
[87] James M. Roberts,et al. lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin , 1994, Nature.
[88] Tony Hunter,et al. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.
[89] M. Skolnick,et al. A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.
[90] DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. , 1994, Molecular and cellular biology.
[91] R. Weinberg,et al. Extensive contribution of Rb‐deficient cells to adult chimeric mice with limited histopathological consequences. , 1994, The EMBO journal.
[92] Gregory J. Hannon,et al. pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest , 1994, Nature.
[93] C. Sherr. G1 phase progression: Cycling on cue , 1994, Cell.
[94] R Montesano,et al. Database of p53 gene somatic mutations in human tumors and cell lines. , 1994, Nucleic acids research.
[95] James M. Roberts,et al. Rules to replicate by , 1994, Cell.
[96] M. Gossen,et al. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. , 1994, Molecular and cellular biology.
[97] J.M. Adams,et al. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.
[98] T. Rabbitts,et al. Chromosomal translocations in human cancer , 1994, Nature.
[99] G. Demers,et al. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[100] R. Weinberg,et al. Growth suppression by p16ink4 requires functional retinoblastoma protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[101] G. Stark,et al. The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. , 1995, Trends in biochemical sciences.
[102] B. Dynlacht,et al. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition , 1995, Nature.
[103] J. Massagué,et al. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.
[104] C. Norbury,et al. Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. , 1995, Trends in biochemical sciences.
[105] R. DePinho,et al. Inhibition of ras-induced proliferation and cellular transformation by p16INK4 , 1995, Science.
[106] S. Weintraub,et al. Mechanism of active transcriptional repression by the retinoblastoma protein , 1995, Nature.
[107] M. Roussel,et al. Rescue of defective mitogenic signaling by D-type cyclins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[108] R. Berger,et al. A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. , 1995, Oncogene.
[109] L. Sandkuijl,et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds , 1995, Nature Genetics.
[110] R. Weinberg,et al. The retinoblastoma protein and cell cycle control , 1995, Cell.
[111] H. Yokozaki,et al. Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas , 1995, Japanese journal of cancer research : Gann.
[112] J. Bartek,et al. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity , 1995, Molecular and cellular biology.
[113] F. Zindy,et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.
[114] S. Elledge,et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.
[115] H. Yokozaki,et al. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas , 1995, International journal of cancer.
[116] D N Shapiro,et al. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4 , 1995, Molecular and cellular biology.
[117] A. Schulze,et al. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[118] M. Pagano,et al. Identification of a Myc‐dependent step during the formation of active G1 cyclin‐cdk complexes. , 1995, The EMBO journal.
[119] J. Bartek,et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 , 1995, Nature.
[120] M. Roussel,et al. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 , 1995, Molecular and cellular biology.
[121] D. Conte,et al. Deregulation of cyclin E in breast cancer. , 1995, Oncogene.
[122] M. Serrano,et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma , 1995, Science.
[123] W. Sellers,et al. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter , 1994, Molecular and cellular biology.
[124] C. D. Edwards,et al. A novel p16INK4A transcript. , 1995, Cancer research.
[125] P. Beer-Romero,et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.
[126] David O. Morgan,et al. Principles of CDK regulation , 1995, Nature.
[127] James Brugarolas,et al. Radiation-induced cell cycle arrest compromised by p21 deficiency , 1995, Nature.
[128] G. Stamp,et al. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. , 1995, Genes & development.
[129] E. Nigg,et al. Cyclin‐dependent protein kinases: Key regulators of the eukaryotic cell cycle , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[130] R. Kerkhoven,et al. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. , 1995, Genes & development.
[131] J. Nevins,et al. Regulation of the cyclin E gene by transcription factor E2F1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[132] D. Livingston,et al. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint , 1995, Cell.
[133] P. O’Farrell,et al. Developmental control of the G1 to S transition in Drosophila: cyclin Eis a limiting downstream target of E2F. , 1995, Genes & development.
[134] E. White,et al. Life, death, and the pursuit of apoptosis. , 1996, Genes & development.
[135] Nobuyuki Shishido,et al. Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.
[136] B. Stillman,et al. Cell Cycle Control of DNA Replication , 1996, Science.
[137] G. Peters,et al. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence , 1996, Molecular and cellular biology.
[138] S. Reed,et al. Activation of cyclin E/CDK2 is coupled to site‐specific autophosphorylation and ubiquitin‐dependent degradation of cyclin E. , 1996, The EMBO journal.
[139] N. Dyson,et al. Ectopic expression of dE2F and dDP induces cell proliferation and death in the Drosophila eye. , 1996, The EMBO journal.
[140] G. Woude,et al. Abnormal Centrosome Amplification in the Absence of p53 , 1996, Science.
[141] R. M. Böhmer,et al. Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. , 1996, Molecular biology of the cell.
[142] A. Hatzigeorgiou,et al. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter , 1996, Molecular and cellular biology.
[143] T. Jacks,et al. Targeted disruption of p107: functional overlap between p107 and Rb. , 1996, Genes & development.
[144] James M. Roberts,et al. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. , 1996, Genes & development.
[145] S. Orkin,et al. The transcriptional control of hematopoiesis. , 1996, Blood.
[146] K. Manova-Todorova,et al. Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.
[147] L. Chin,et al. Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.
[148] K. Palucka,et al. Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage. , 1996, Blood.
[149] R. Weinberg,et al. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts , 1996, Molecular and cellular biology.
[150] A. Schulze,et al. Copyright � 1996, American Society for Microbiology Anchorage-Dependent Transcription of the Cyclin A Gene , 1996 .
[151] J. Nevins,et al. Ectopic E2F expression induces S phase and apoptosis in Drosophila imaginal discs. , 1996, Genes & development.
[152] D. Beach,et al. Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.
[153] R. Weinberg,et al. Shared role of the pRB-related p130 and p107 proteins in limb development. , 1996, Genes & development.
[154] James M. Roberts,et al. Requirement of p27Kip1 for Restriction Point Control of the Fibroblast Cell Cycle , 1996, Science.
[155] G. Peters,et al. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. , 1996, Advances in cancer research.
[156] J. Bartek,et al. Abrogation of p27Kip1 by cDNA Antisense Suppresses Quiescence (G0 State) in Fibroblasts* , 1996, The Journal of Biological Chemistry.
[157] J. S. Kang,et al. Ras induces anchorage-independent growth by subverting multiple adhesion-regulated cell cycle events , 1996, Molecular and cellular biology.
[158] R. Kerr. Ice Rhythms—Core Reveals a Plethora of Climate Cycles , 1996, Science.
[159] James M. Roberts,et al. A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.
[160] T. Hunter,et al. Dependence of Cyclin E-CDK2 Kinase Activity on Cell Anchorage , 1996, Science.
[161] R. Kolodner,et al. Biochemistry and genetics of eukaryotic mismatch repair. , 1996, Genes & development.
[162] P. Nurse,et al. Regulating S Phase: CDKs, Licensing and Proteolysis , 1996, Cell.
[163] M. Ewen,et al. Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[164] R. Weinberg,et al. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. , 1996, Oncogene.
[165] M. Greenberg,et al. E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation , 1996, Cell.
[166] W. B. Smith,et al. A Role for Endothelial NO Synthase in LTP Revealed by Adenovirus-Mediated Inhibition and Rescue , 1996, Science.
[167] W. J. Pledger,et al. Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells , 1996, Molecular and cellular biology.
[168] L. Hengst,et al. Translational Control of p27Kip1 Accumulation During the Cell Cycle , 1996, Science.